circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression
circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression is a paper indexed in ScholarIQ from OpenAlex.
How many citations does circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression have?
circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression has 310 citations in the OpenAlex counts ScholarIQ stores.
When was circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression published?
circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression has 2018 year in the ScholarIQ index.
What is the open-access status of circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression?
circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression has gold oa status in the ScholarIQ index.
What is the DOI of circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression?
The DOI for circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression is on the source record.
What is the PMID of circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression?
The PMID for circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression is on the source record.
What is the OpenAlex record for circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression?
The OpenAlex for circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression is on the source record.